Trial Profile
PSORIASIS AND CARDIOVASCULAR DISEASE: IMMUNOMODULATOR ROLE OF THE TREATMENT WITH ROSUVASTATIN IN PATIENTS WITH PSORIASIS OF MILD OR OF MODERATE-SEVERE SKIN DISEASE.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 19 Jun 2014
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Inflammation
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 19 Jun 2014 New trial record